Wuhan Kangzhou Medical Technology Co., Ltd. (hereinafter referred to as "Kangzhou Medical") is a technology-based enterprise specializing in animal disease diagnosis and food safety testing. The company is committed to providing high-quality disease diagnosis and epidemic prevention testing products for the animal husbandry industry; Provide reliable clinical diagnostic products for companion animals; Provide high-quality, convenient and fast testing products for food safety testing.

Kangzhou Medical Products has strong R&D capabilities and currently has a dedicated R&D team of 10 people, including 4 with doctoral or above degrees, 2 with master's degrees, and 4 with bachelor's degrees. The project leader has been engaged in the research and development and production management of in vitro diagnostic reagents for 17 years. The team members are all professionals in related fields, and have worked in internationally renowned in vitro diagnostic reagent units such as Hangzhou Aikang and Shengxiang Biology. They have rich experience in research and development and technology transformation. At the same time, Kangzhou Medical attaches great importance to cooperation between industry, academia, and research. It has carried out project development cooperation with pet hospitals of Huazhong Agricultural University, medical schools of Hubei University of Science and Technology, and other universities. On this basis, it has jointly established a joint training base for professional direct talent.

Kangzhou Medical has four leading domestic technology platforms in the field of in vitro diagnostic reagents: fluorescence quantitative chromatography (POCT), magnetic particle tube chemiluminescence, colloidal gold, and dry chemistry; The company's products cover over 60 in vitro diagnostic products for diseases applicable to companion animals (dogs, cats) and economic animals (pigs, cows, sheep, and poultry). The performance of the products has been comprehensively evaluated by multiple high-level laboratories and has been unanimously recognized. As of now, the company is applying for 18 independent intellectual property rights, including 4 invention patents, 13 utility model patents, and 1 software copyright.

Since its establishment, the company has always adhered to the concept of "improving product performance, improving quality control capabilities, and improving service quality always on the way", committed to transforming advanced technology and the pursuit of extreme attitude into high-quality products and services, helping users improve the accuracy and convenience of disease diagnosis and prevention, and providing users with the best solutions.